Actimis Pharmaceuticals Lands $9,600,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=50785e4d-54df-4df1-8fa8-c630074ea0d6&Preview=1 -
Date
6/30/2008 -
Company Name
Actimis Pharmaceuticals -
Mailing Address
10835 Road To The Cure San Diego, CA 92121 -
Company Description
Actimis Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. -
Website
http://www.actimis.com -
Transaction Type
Venture Equity -
Transaction Amount
$9,600,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Sanderling Ventures -
Venture Investor
Undisclosed
